Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
By year’s end, a new crop of interferon-free hepatitis C combination therapies will likely hit the market.
Combo cured all study participants who had genotype 1b of hep C, did not have cirrhosis and had previously failed interferon-based treatment
Daclatasvir and Sovaldi, given with or without ribavirin, cured between 92 and 100 percent of people with genotypes 1, 2 and 3 of hepatitis C.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.